glp 1 drugs list GLP-1 Market Industry Trends and Global Forecasts 2024-2035: Over 150 GLP-1 Drug Candidates in Development for Multiple Indications, Type 2 Diabetes and Obesity Drive GLP-1 Drug Development Boom Weight loss drugs don't work
Description
The ease of administration and long-term management of diabetes and obesity with oral GLP-1 receptor agonist is driving their widespread adoption
According to public reports, the clinical trial version of the new drug failed to help participants lose more weight than those who took Zepbound
He and other experts are working on subsequent research examining the effects of different diabetes treatments on other health outcomes and concerns, including a patients risk of cancer, blindness or amputation
doi: 10.1016/S0140-6736(17)31585-4, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 83.Mulvaney CA, Duarte GS, Handley J, Evans DJ, Menon S, Wyse R, et al
